基于干细胞的治疗病:机制,来源,临床转化和新兴策略
Xinru Feng1,2, Bo Xiao3, Lixia Hou3
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Frontiers in immunology
|March 6, 2026
概括
干细胞疗法在治疗不可逆转的肺部疾病 - - 症方面表现有前途. 本综述探讨了介质干细胞 (MSC) 和其他来源,挑战以及临床应用的未来策略.
科学领域:
- 肺部医学和再生生物学
- 毒理学和职业健康 职业健康
- 干细胞生物学和治疗方法
背景情况:
- 病是一种不可逆转的纤维化间歇性肺部疾病,是由可呼吸晶体二氧化 (RCS) 暴露引起的.
- 目前对病的治疗方法是缓解性,重点是缓解进展,而不是逆转肺损伤.
- 基于干细胞的疗法为解决病的潜在病理机制提供了一个有希望的途径.
研究的目的:
- 审查和综合基于干细胞的病治疗策略的最新进展.
- 系统地比较关键干细胞来源,包括介质干细胞 (MSC),气道基底干细胞 (ABSC) 和诱导多能干细胞 (iPSC).
- 讨论这些疗法的临床转化所面临的挑战和创新策略.
主要方法:
- 系统审查目前关于干细胞治疗病和相关肺纤维性疾病的文献.
- 干细胞特性分析,包括免疫调节作用和再生潜力.
- 对肺纤维化中介质干细胞 (MSCs) 的临床试验数据的评估.
主要成果:
- 在肺纤维化早期临床试验中,介质干细胞 (MSC) 已经证明了初步的安全性和肺功能稳定性的潜力.
- 各种干细胞类型针对关键的化途径:NLRP3炎症体,TGF-β1/Smad纤维化和免疫失衡.
- 挑战包括标准化良好制造实践 (GMP) 生产,改善干细胞定位,解决安全风险.
结论:
- 干细胞疗法,特别是MSC,对病具有显著的治疗潜力,向其纤维化和炎症性质.
- 创新策略,如CRISPR工程细胞,纳米输送系统和器官模型,对于克服翻译障碍至关重要.
- 未来的方向包括组合疗法和针对性治疗病并发症,以改善临床结果.
相关概念视频
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Mesenchymal Stem Cells
5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K


